ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules

BAUDETTE, Minn., June 30, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. mark... Biopharmaceuticals, Cardiology, Generics, Product Launch ANI Pharmaceuticals, Mexiletine, arrhythmia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news